In normal cells, wild-type p53 can activate downstream target genes, such as GADD45, p21, Bax, Fas, Puma, and Cyclin, to regulate the cell cycle, repair DNA damage, induce cell apoptosis, and inhibit angiogenesis, thereby inhibiting cancer. The gene discussed is TP53; the disease is cancer.